The preparation for the COVID-19 treatment is registered by Rospatent


The first preparation for coronavirus, the pandemic of which has swept the whole world and killed more than 700 thousand people, is registered by Rospatent. The Office has already made a decision to grant a patent, and the document is being finalized. “Hexapeptide Tyr-D-Ala-Gly-Phe-Leu-Arg is a completely domestic development, - noted in Rospatent. - Its uniqueness lies in the fact that it does not repeat foreign experience in anything. It is the first and only one so far in the world's delta-opioid receptor agonist who has gone out into practical medicine". The generic name for the parent compound is dalargin and was previously used to treat stomach ulcers, acute pancreatitis and pancreatic necrosis.


Primary source




Last page update:

All updates
next news
Working Group on the WIPO Madrid System: the 19th Session Concluded
go to news list

Font size